Search
for
Sort by
Research 121–150 of 290
- Anti‐androgens may protect against severe COVID‐19 outcomes: results from a prospective cohort study of 77 hospitalized men
- Evaluating cepharanthine analogues as natural drugs against SARS‐CoV‐2
- Immuno-Endocrinology of COVID-19: The Key Role of Sex Hormones
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Large Screening Identifies ACE2 Positively Correlates With NF-κB Signaling Activity and Targeting NF-κB Signaling Drugs Suppress ACE2 Levels
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- Association between Mineralocorticoid Receptor Antagonist and Mortality in SARS-CoV-2 Patients: A Systematic Review and Meta-Analysis
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Novel Synthetic Steroid Derivatives: Target Prediction and Biological Evaluation of Antiandrogenic Activity
- O papel dos andrógenos na alopecia androgenética associada à gravidade do COVID-19
- Roles of steroid receptors in the lung and COVID-19
- Fármacos de uso frecuente en dermatología como terapia para COVID-19
- Antiandrogenic activity of Riboflavin 5′-phosphate (FMN) in 22Rv1 and LNCaP human prostate cancer cell lines
- Insights into disparities observed with COVID‐19
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Understanding sex and gender disparities in COVID-19 mortality: a narrative review beyond biology
- Two years of SARS-CoV-2 infection (2019–2021): structural biology, vaccination, and current global situation
- 2022 Update on Prostate Cancer Epidemiology and Risk Factors—A Systematic Review
- COVID-19 and Sex Differences
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign”
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Long-Term Effects of COVID-19
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Coronavirus Infection and Cholesterol Metabolism
- Role of Endolysosomes in Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Coronavirus Disease 2019 Pathogenesis: Implications for Potential Treatments
- Coronavirus 2019 Infectious Disease Epidemic: Where We Are, What Can Be Done and Hope For
- Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
- Antiviral and Anti-Inflammatory Plant-Derived Bioactive Compounds and Their Potential Use in the Treatment of COVID-19-Related Pathologies